Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Income from Continuing Operations fell 2681.1% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 6922.09%. This contributed to the annual value of -$6.4 million for FY2024, which is 178.41% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Income from Continuing Operations of -$1.9 million as of Q3 2025, which was down 2681.1% from -$735207.0 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Income from Continuing Operations peaked at $1.2 million during Q1 2025, and registered a low of -$6.3 million during Q4 2023.
  • For the 5-year period, Cumberland Pharmaceuticals' Income from Continuing Operations averaged around -$1.3 million, with its median value being -$1.4 million (2022).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Income from Continuing Operations crashed by 120425.22% in 2024 and then soared by 16560.85% in 2025.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Income from Continuing Operations stood at -$4.4 million in 2021, then soared by 43.94% to -$2.5 million in 2022, then tumbled by 156.21% to -$6.3 million in 2023, then soared by 69.82% to -$1.9 million in 2024, then fell by 2.49% to -$1.9 million in 2025.
  • Its last three reported values are -$1.9 million in Q3 2025, -$735207.0 for Q2 2025, and $1.2 million during Q1 2025.